New Estimates on the Cost of a Delay Day in Drug Development and What This Means for You – A Discussion with Ken Getz

About This Webinar

Sponsored by ClinEco & SCOPE Summit

Speed is a critical success factor in clinical research given the high cost and lengthy timelines to develop a new drug or biologic. The financial value of time is an essential measure used to mobilize and motivate clinical research teams, to inform return on development investment and resource planning. Vendors and sales professionals cite the financial value of time when communicating the value proposition of a service or solution.

Two financial measures that are most commonly referenced -- the cost of missing a day to generate prescription drug sales and the cost of a day to conduct a clinical trial -- are antiquated estimates introduced in the 1990s. A recent study conducted by the Tufts Center for the Study of Drug Development (CSDD) updates measures of the financial value of a delay day, tests whether average financial value has changed over time, and provides more granular measures by major disease condition.

Join Ken Getz for a discussion about this groundbreaking report and what it means for drug development stakeholders — sponsors, CROs and service providers — and for your own company.

Topics to be addressed:

• Learn about the new and updated value of a delay day in drug development overall and by individual disease conditions
• Review how the estimates were derived
• Understand the implications of this new value of time
• Identify and anticipate new practices and approaches to optimize the value of time and drive efficiency

Privacy Policy

Who can view: Everyone

Webinar Price: Free

Webinar ID: cb99279f30b1

Featured Presenters

Ken Getz, MBA

Executive Director and Professor, Tufts Center for the Study of Drug Development, Tufts University School of Medicine; Founder and Board Chair, CISCRP

Mr. Getz is an internationally recognized expert on R&D and clinical trial management practices and trends, the global investigative site landscape, site management and patient recruitment and retention practices, and the worldwide market for outsourcing clinical research functions. Mr. Getz’s research studies on protocol design complexity and clinical research efficiency and effectiveness, conducted over the past two decades, are considered by many in the research-based life sciences industry to be pioneering work. His 20+ years of original research benchmarking R&D management practices, global outsourcing and the investigative site landscape have contributed to industry-wide understanding of these critical markets and to improvements in management strategy and execution.

VIEW PROFILE

Micah Lieberman

Co-Founder, VP, Community and Business Development, ClinEco

Micah has 20 years of experience in the biopharma industry. He is an Executive Director at Cambridge Healthtech Institute (CHI) where he is a producer, content developer, and facilitator of the Summit for Clinical Ops Executives (SCOPE), the leading event in the US and Europe for biopharmaceutical industry executives focused on driving innovation in clinical trials and digital health. On a daily basis, he builds a broad community of clinical research stakeholders and industry thought leaders, performs market research, and ascertains ever-changing industry trends in clinical trial optimization, clinical innovation, patient recruitment, digital health, drug development, clinical trial technology, and population health. He is also the Co-founder and Vice President of Community and Business Development of ClinEco. ClinEco unites sponsors, CROs, service providers, and sites on the world's first B2B global clinical trial marketplace so each can expand clinical partnerships. SCOPE and ClinEco are owned by Cambridge Healthtech Institute (CHI). Please join our SCOPE and ClinEco communities! https://clineco.io/; www.SCOPEsummit.com; www.SCOPEsummiteurope.com

VIEW PROFILE

Erik Yorke

Marketing Lead and Scientific Writer, ClinEco

Erik Yorke is the Marketing Lead for ClinEco where he also serves as the team’s scientific writer. For more than 20 years, Erik has helped companies in a variety of industries develop effective content strategies that build trust, grow reputation, and generate leads. His clinical research communications experience goes back more than 10 years, with him working closely with clients involved in patient recruitment, decentralized clinical trials, clinical trial data management, and more.

VIEW PROFILE

Hosted By

CII Webinars

VIEW CHANNEL CONTACT

Recommended